Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $38.09M | $47.34M | $24.82M | $23.50M |
| Net Income | -$10.13M | — | -$17.89M | -$25.15M |
| EPS Diluted | -$0.09 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.18 |
| -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.